Lateral Femoral Bowing and the Location of Atypical Femoral Fractures
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Purpose: Atypical femoral fractures (AFFs) occur in two distinct part, subtrochanter and diaphysis. The aim of this study was to investigate the relationship between the lateral femoral bowing angle and the location of AFF. Materials and Methods: This study included a total of 56 cases in 45 patients who underwent surgical treatment between January 2010 and December 2015. For the diaphyseal and subtrochanteric AFFs, we evaluated the relationship between the anatomic location and lateral femoral bowing angle. Lateral femoral bowing angle was measured by two orthopaedic surgeons and average value of two calibrators was used in statistic analysis. Other variables like age, height, weight, body mass index and bone mineral density were also evaluated. We also calculated the cutoff value for the location of the fractures from the raw data. Results: The average lateral femoral bowing angle was 10.10。±3.79。(3。-19。) in diaphyseal group and 3.33。±2.45。(1.5。-11。) in subtrochanter group. Lateral femoral bowing angle was statistically significant in logistic regression analysis. According to the receiver operating characteristic curve, cutoff value for the location of the fracture was 5.25。. In other words, the femoral diaphyseal fractures are more frequent if the lateral femoral bowing angle is greater than 5.25。. Conclusion: The lateral femoral bowing angle is associated with the location of the AFFs and the cutoff value of lateral femoral bowing angle was 5.25。.
Abstract
Purpose: Atypical femoral fractures (AFFs) occur in two distinct part, subtrochanter and diaphysis. The aim of this study was to investigate the relationship between the lateral femoral bowing angle and the location of AFF. Materials and Methods: This study included a total of 56 cases in 45 patients who underwent surgical treatment between January 2010 and December 2015. For the diaphyseal and subtrochanteric AFFs, we evaluated the relationship between the anatomic location and lateral femoral bowing angle. Lateral femoral bowing angle was measured by two orthopaedic surgeons and average value of two calibrators was used in statistic analysis. Other variables like age, height, weight, body mass index and bone mineral density were also evaluated. We also calculated the cutoff value for the location of the fractures from the raw data. Results: The average lateral femoral bowing angle was 10.10。±3.79。(3。-19。) in diaphyseal group and 3.33。±2.45。(1.5。-11。) in subtrochanter group. Lateral femoral bowing angle was statistically significant in logistic regression analysis. According to the receiver operating characteristic curve, cutoff value for the location of the fracture was 5.25。. In other words, the femoral diaphyseal fractures are more frequent if the lateral femoral bowing angle is greater than 5.25。. Conclusion: The lateral femoral bowing angle is associated with the location of the AFFs and the cutoff value of lateral femoral bowing angle was 5.25。.
참고문헌 (23)
- Black DM, "Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group", Lancet, 348, pp.1535~1541 (1996)
- Harris ST, "Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group", JAMA, 282, pp.1344~1352 (1999)
- McClung MR, "Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group", N Engl J Med, 344, pp.333~340 (2001)
- Black DM, "Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis", N Engl J Med, 356, pp.1809~1822 (2007)
- Chesnut CH 3rd, "Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis", J Bone Miner Res, 19, pp.1241~1249 (2004)
- Odvina CV, "Severely suppressed bone turnover : a potential complication of alendronate therapy", J Clin Endocrinol Metab, 90, pp.1294~1301 (2005)
- Thompson RN, "Atypical femoral fractures and bisphosphonate treatment : experience in two large United Kingdom teaching hospitals", J Bone Joint Surg Br, 94, pp.385~390 (2012)
- Kang JS, "Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study", Int Orthop, 38, pp.1247~1253 (2014)
- Schilcher J, "Bisphosphonate use and atypical fractures of the femoral shaft", N Engl J Med, 364, pp.1728~1737 (2011)
- Giusti A, "Atypical fractures and bisphosphonate therapy : a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features", Bone, 48, pp.966~971 (2011)
- Shane E, "Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research", J Bone Miner Res, 29, pp.1~23 (2014)
- Koh JS, "Distribution of atypical fractures and cortical stress lesions in the femur:implications on pathophysiology", Singapore Med J, 52, pp.77~80 (2011)
- Yau WP, "Coronal bowing of the femur and tibia in Chinese: its incidence and effects on total knee arthroplasty planning", J Orthop Surg (Hong Kong), 15, pp.32~36 (2007)
- Koch JC, "The laws of bone architecture", Am J Anat, 21, pp.177~298 (1917)
- Oh Y, "Potential pathogenic mechanism for stress fractures of the bowed femoral shaft in the elderly: Mechanical analysis by the CT-based finite element method", Injury, 45, pp.1764~1771 (2014)
- Goh SK, "Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution", J Bone Joint Surg Br, 89, pp.349~353 (2007)
- Meier RP, "Increasing occurrence of atypical femoral fractures associated with bisphosphonate use", Arch Intern Med, 172, pp.930~936 (2012)
- Beaudouin-Bazire C, "Real frequency of ordinary and atypical sub-trochanteric and diaphyseal fractures in France based on X-rays and medical file analysis", Joint Bone Spine, 80, pp.201~205 (2013)
- Lo JC, "Clinical correlates of atypical femoral fracture", Bone, 51, pp.181~184 (2012)
- Sasaki S, "Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series", J Bone Miner Metab, 30, pp.561~567 (2012)
- Park-Wyllie LY, "Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women", JAMA, 305, pp.783~789 (2011)
- Feldstein AC, "Incidence and demography of femur fractures with and without atypical features", J Bone Miner Res, 27, pp.977~986 (2012)
- Dell RM, "Incidence of atypical nontraumatic diaphyseal fractures of the femur", J Bone Miner Res, 27, pp.2544~2550 (2012)